hme

What are the key drivers for selecting ideal RRMM patients for treatment with CAR T-cell therapy?

Agenda

Learning objective:

After participating in this webinar, viewers should be able to:

  • Explain what the key drivers are when selecting RRMM patients for treatment with CAR T-cell therapy

 

Faculty:

  • Michel Delforge (Belgium)
  • Joaquin Martinez-Lopez (Spain)
  • Herman Einsele (Germany)

 

More Info
45 Minutes
EM-93624 - Date of preparation: March 2022